会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Preparation of 2-substituted-6-pyridyl-nicotinic acids
    • 2-取代-6-吡啶基 - 烟酸的制备
    • US3928366A
    • 1975-12-23
    • US45280674
    • 1974-03-20
    • STERLING DRUG INC
    • BRUNDAGE RUTH PAULINELESHER GEORGE Y
    • C07D213/80C07D471/04C07D213/22
    • C07D213/80C07D471/04
    • Intermediate 2-R1NH-6-Q''''''-nicotinic acid (V''), where R1 is lower-alkyl and Q'''''' is 4(or 3)-pyridyl or 4(or 3)-pyridyl having one or two lower-alkyl substituents, is prepared in the three steps of: hydrolyzing 1,2-dihydro-2-oxo-6-Q''''''-nicotinonitrile (VII) to produce 1,2-dihydro-2-oxo-6-Q''''''-nicotinic acid (VIII); halogenating VIII to produce 2-halo-6-Q''''''-nicotinic acid (VI''); and, reacting VI'' with R1NH2 to produce V''. Also shown are the steps of: reacting 2-halo-6-Q''''-nicotinic acid (VI), where Q'''' is as Q'''''' and also lower-alkyl, to produce 2-R1NH-6-Q''''-nicotinic acid (V); heating V with a lower-alkyl chloroformate or phosgene to produce 1-R1-7-Q''''-1H,4H-pyrido(2,3-d)(1,3)oxazine-2,4-dione (I''); converting I'' where Q'''' is CH3 to its 8-oxide and reacting the 8-oxide with a lower-alkanoic acid anhydride to produce I where 7-CH3 is converted to 7-(lower-alkanoyloxymethyl); reacting 1-R1-7-Q-1H,4H-pyrido(2,3-d)(1,3)oxazine-2,4-dione, where Q is as Q'''' and also lower-alkanoyloxymethyl, with R2-C( O)CH2COOR, where R2 is H or CH3 and R is lower-alkyl, to produce lower-alkyl 1-R11,4-dihydro-2-R2-4-oxo-7-Q-1,8-naphthyridine-3-carboxylate (III); and, hydrolyzing III to obtain 1-R1-1,4-dihydro-2-R2-4-oxo-7-Q''1,8-naphthyridine-3-carboxylic acid (IV), where Q'' is like Q but having hydroxymethyl in place of lower-alkanoyloxymethyl.
    • 中间体2-R1NH-6-Q“ - 烟酸(V'),其中R 1是低级烷基且Q”是4或(3) - 吡啶基或具有一个或两个的4(或3) - 吡啶基 低级烷基取代基在三个步骤中制备:水解1,2-二氢-2-氧代-6-Q“ - 烟腈(Ⅶ),得到1,2-二氢-2-氧代-6-Q 烟酸(VIII); 卤化VIII产生2-卤代-6-Q“ - 烟酸(VI'); 并使VI'与R1NH2反应产生V'。 还示出了以下步骤:使2-卤代-6-Q“ - 烟酸(VI)反应,其中Q”为Q“且为低级烷基,以产生2-R 1 NH-6-Q' - 烟酸(V); 用氯甲酸低级烷基酯或光气加热V,得到1-R1-7-Q“-1H,4H-吡啶并[2,3-d] [1,3]恶嗪-2,4-二酮(I' ; 将Q“为CH 3的I'转化为8-氧化物,并使8-氧化物与低级链烷酸酐反应以产生I,其中7-CH 3转化为7-(低级 - 烷酰氧基甲基); 使1-R1-7-Q-1H,4H-吡啶并[2,3-d] [1,3]恶嗪-2,4-二酮,其中Q为Q“,低级烷酰氧基甲基, C(= O)CH 2 COOR,其中R 2为H或CH 3且R为低级烷基,得到低级烷基1-R 1-1,4-二氢-2-基-2-氧代-7-Q-1, 8-萘啶-3-羧酸酯(III); 并且水解III得到1-R 1 -1,4-二氢-2-基-2-氧代-7-Q'-1,8-二氮杂萘-3-羧酸(Ⅳ),其中Q'如Q,但是 具有羟甲基代替低级烷酰氧基甲基。
    • 5. 发明授权
    • Preparation of 4H-pyrido{8 1,2-a{9 pyrimidin-4-ones from cyclic alkylidene 2-pyridylaminomethylenemalonates
    • 从环状亚烷基2-吡啶基氨基亚甲基戊二酸酯制备4H-吡啶并[1,2-a {9H-嘧啶-4-酮
    • US3907798A
    • 1975-09-23
    • US35094873
    • 1973-04-13
    • STERLING DRUG INC
    • LESHER GEORGE Y
    • C07D215/38C07D319/06C07D471/04C07D487/04
    • C07D215/38C07D319/06C07D471/04
    • Alkylidene Ar-aminomethylenemalonates, where Ar is an aromatic radical having one or two aromatic rings which can be benzenoid or five- or six-membered heteroaromatic, are prepared by reacting the appropriate aromatic-amine with a mixture of a trialkyl orthoformate or trialkyl orthoacetate and an alkylidene malonate. The alkylidene Ar-aminomethylenemalonates are then cyclized by heating to provide an improved process for preparing various heterocyclic compounds, e.g., a 4-hydroxyquinoline from an alkylidene anilinomethylenemalonate, a 4H-pyrido(1,2-a)pyrimidin4-one from an alkylidene 2-pyridylaminomethylenemalonate, a 4Hpyrimido(1,2-a)pyrimidine-4-one from an alkylidene 2pyrimidylaminomethylenemalonate. The cyclized products are useful as intermediates for the preparation of antimalarials and antiinflammatory agents.
    • 亚烷基Ar-氨基亚甲基戊二酸酯,其中Ar是具有一个或两个可以是苯或五元或六元杂芳基的芳环的芳基,其通过使适当的芳族胺与原甲酸三烷基酯或原乙酸三烷基酯的混合物和 丙二酸亚烷基酯。 亚烷基Ar-氨基亚甲基戊二酸酯然后通过加热环化以提供制备各种杂环化合物的改进方法,例如来自亚烷基苯胺基亚甲基丙二酸酯的4-羟基喹啉,4H-吡啶并[1,2-a]嘧啶-4-酮 亚烷基2-吡啶基氨基亚甲基丙二酸酯,4-嘧啶基亚氨基亚甲基丙二酸亚苄基酯,4H-嘧啶并[1,2-a]嘧啶-4-酮。 环化产物可用作制备抗疟药和抗炎剂的中间体。
    • 7. 发明授权
    • 2-{8 {60 -Alkoxy-arylmethyl{9 -2-imidazolines and -1,4,5,6-tetrahydropyrimidines
    • 2- {8 {6-烷氧基 - 芳基甲基{9-2-咪唑啉和-1,4,5,6-四氢嘧啶
    • US3897431A
    • 1975-07-29
    • US35094973
    • 1973-04-13
    • STERLING DRUG INC
    • BAILEY DENIS M
    • C07C43/174C07C51/00C07D233/22C07D239/06
    • C07D239/06C07C43/174C07C43/1742C07C51/00C07D233/22Y10S514/866Y10S514/869C07C65/24
    • 2-( Alpha -(Lower-alkoxy)- Alpha -R1-Ar-methyl)-2-imidazolines, -1,4,5,6-tetrahydropyrimidines and -4,5,6,7-tetrahydro-1H-1,3diazepines, having pharmacological properties, e.g., hypoglycemic, diuretic, anti-inflammatory, are prepared by heating a 2-(lower-alkoxy)-2-Ar-alkanenitrile with an alkanediamine, wherein 2, 3 or 4 carbon atoms respectively intervene between the two amino groups, in the presence of a catalytic amount of carbon disulfide or hydrogen sulfide, where R1 is hydrogen, lower-alkyl or lower-alkenyl, Ar is phenyl, naphthyl, indanyl, biphenylyl, cyclohexenyl, cyclohexyl and phenyl substituted by from one to three substituents selected from lower-alkyl, lower-alkoxy, halo, trihalomethyl, loweralkylmercapto, lower-alkylsulfonyl, di-(lower-alkyl)amino, amino, hydroxy, nitro, hydroxyamino and benzyloxy. The intermediate 2(lower-alkoxy)-2-Ar-alkanenitriles are prepared preferably by first reacting an aldehyde of the formula Ar-CHO with a tri(lower-alkyl) orthoformate to form the aldehyde di-(lower-alkyl) acetal, reacting the latter with an acyl halide to form the corresponding Alpha -halo-Ar-methyl lower-alkyl ether and reacting said ether with an alkali cyanide to yield said intermediate nitrile.
    • 2- [α-(低级 - 烷氧基)-α-R1-Ar-甲基] -2-咪唑啉,-1,4,5,6-四氢嘧啶和-4,5,6,7-四氢-1H-1, 通过加热2-(低级烷氧基)-2- Ar-烷腈与链烷二胺(其中2,3或4个碳原子分别干预)制备具有药理学性质的3-二氮杂,例如降血糖,利尿,抗炎, 在两个氨基之间,在催化量的二硫化碳或硫化氢的存在下,其中R 1是氢,低级烷基或低级链烯基,Ar是苯基,萘基,茚满基,联苯基,环己烯基,环己基和被 一个至三个选自低级烷基,低级烷氧基,卤素,三卤代甲基,低级烷基巯基,低级烷基磺酰基,二 - (低级 - 烷基)氨基,氨基,羟基,硝基,羟基氨基和苄氧基的取代基。 中间体2-(低级烷氧基)-2- Ar-亚烷基腈优选通过首先使式Ar-CHO的醛与三(低级烷基)原甲酸酯反应形成醛二 - (低级 - 烷基) 缩醛,使后者与酰基卤反应形成相应的α-卤代-Ar-甲基低级烷基醚,并使所述醚与碱金属氰化物反应,得到所述中间体腈。
    • 8. 发明授权
    • 9-Amino-3-(amino or nitro)-1,5-dioxaspiro{8 5.5{9 undecane derivatives
    • 9-氨基-3-(氨基或硝基)-1,5-二氧杂螺[{8,55}十一烷衍生物
    • US3895036A
    • 1975-07-15
    • US46238974
    • 1974-04-19
    • STERLING DRUG INC
    • GELOTTE KARL OSURREY ALEXANDER R
    • C07D319/08C07D319/06A61K31/335
    • C07D319/08
    • 9-(Ac1NH)-3-Q-3-R-9-R''-1,5-dioxaspiro(5.5)undecane (I), where R and R'' are each hydrogen or lower-alkyl, Ac1 is hydrogen or lower-alkanoyl and Q is NO2 or NH2, are useful intermediates for the preparation of antifertility agents, namely, 3-(Ac4NH)-9(Ac3NH)-3-R-9-R''-1,5-dioxaspiro(5.5)undecane (II), where Ac3 is lower-alkanoyl or 4-Q1-benzoyl, Ac is 4-Q2-benzoyl, Q1 and Q2 are each lower-alkoxy or polyhalo-lower-alkoxy, and, R and R'' are each hydrogen or lower-alkyl. II is prepared by diacylating I where Ac1 is hydrogen and Q is NH2 (VII) or by monoacylating I where Ac1 is lower-alkanoyl and Q is NH2 (VI). VI and VII are prepared stepwise as follows: 4-(Ac5NH)-4-R''-cyclohexanol (X), where Ac5 is lower-alkanoyl, is oxidized to produce 4-(Ac5NH)-4R''-cyclohexanone (III); III is reacted with 2-NO2-R-1,3propanediol (IV) to produce 9-(Ac5NH)-3-nitro-3-R-9-R''-1,5dioxaspiro(5.5)undecane (V); V is reduced to produce 3-amino-9(Ac5NH)-3-R-9-R''-1,5-dioxaspiro(5.5)undecane (VI); and, VI is hydrolyzed to produce 3-R-9-R''-1,5-dioxaspiro(5.5)undecan-3,9diamine (VII). Methods of preparing X are given. Bis(polyhaloacetyl) derivatives of VII are prepared.
    • 9-(Ac1NH)-3-Q-3-R-9-R'-1,5-二氧杂螺[5.5]十一烷(I),其中R和R'各自为氢或低级烷基,Ac1为氢或低级 - 烷酰基和Q是NO 2或NH 2,是制备抗生素剂的有用的中间体,即3-(Ac4NH)-9-(Ac3NH)-3-R-9-R'-1,5-二氧杂螺[5.5] 十一碳烷(II),其中Ac 3是低级烷酰基或4-Q1-苯甲酰基,Ac是4-Q2-苯甲酰基,Q1和Q2各自是低级烷氧基或多卤代低级烷氧基,R和R'各自为氢 或低级烷基。 II通过二酰化I制备,其中Ac1是氢,Q是NH2(VII)或通过单酰化I,其中Ac1是低级烷酰基,Q是NH2(VI)。 VI和VII分步制备如下:4-(Ac 5 NH)-4-R'-环己醇(X),其中Ac 5是低级 - 烷酰基,被氧化生成4-(Ac5NH)-4-R'-环己酮(III ); III与2-NO 2 -R-1,3-丙二醇(IV)反应,生成9-(Ac5NH)-3-硝基-3-R-9-R'-1,5-二氧杂螺[5.5]十一烷(V ); V被还原以产生3-氨基-9-(Ac 5 NH)-3-R-9-R'-1,5-二氧杂螺[5.5]十一烷(VI); 并将VI水解,得到3-R-9-R'-1,5-二氧杂螺[5.5]十一烷-3,9-二胺(VII)。 给出了X的制备方法。 制备VII的双(多卤乙酰)衍生物。
    • 9. 发明授权
    • 3-Acetyl-1-alkyl-1,4-dihydro-4-oxo-1,8-naphthyridines and intermediates
    • 3-乙酰基-1-烷基-1,4-二氢-4-氧代-1,8-萘啶和中间体
    • US3895017A
    • 1975-07-15
    • US45392874
    • 1974-03-22
    • STERLING DRUG INC
    • LESHER GEORGE YBRUNDAGE RUTH PAULINE
    • C07D471/04C07D31/36
    • C07D471/04
    • Process of reacting 2-amino-6-Q''-pyridine (I) with lower-alkyl (lower-alkoxy)methyleneacetoacetate (II) to produce lower-alkyl Alpha -(6-Q''-2-pyridylaminomethylene)acetoacetate (III''), heating lower-alkyl Alpha -(6-Q-2-pyridylaminomethylene)acetoacetate (III), to produce 3-acetyl-1,4-dihydro-7-Q-4-oxo-1,8naphthyridine (IV) which is tautomeric with 3-acetyl-4-hydroxy-7Q-1,8-naphthyridine (IVA), reacting IV (or IVA) with a loweralkylating agent to produce 3-acetyl-1-(lower-alkyl)-1,4-dihydro7-Q-4-oxo-1,8-naphthyridine (V) and converting V to 1-(loweralkyl)-1,4-dihydro-7-Q-4-oxo-1,8-naphthyridine-3-carboxylic acid (VI), where Q is lower-alkyl, hydroxymethyl, loweralkanoyloxymethyl, 4(or 3)-pyridyl or 4(or 3)-pyridyl having one or two lower-alkyl substituents, and Q'' is like Q but excluding lower-alkanoyloxymethyl. The compounds of formula VI are known antibacterial agents. Also given are alternative routes of preparing III and IV where Q is lower-alkanoyloxymethyl by reacting the N-oxides of III and IV, respectively, where Q is methyl with a lower-alkanoic acid anhydride.
    • 使2-氨基-6-Q'-吡啶(I)与低级烷基(低级烷氧基)亚甲基乙酰乙酸酯(II)反应生成低级烷基α-(6-Q'-2-吡啶基氨基亚甲基)乙酰乙酸酯(III' ),加热低级烷基α-(6-Q-2-吡啶基氨基亚甲基)乙酰乙酸酯(III),得到3-乙酰基-1,4-二氢-7-Q-4-氧代-1,8-萘啶(IV) 其与3-乙酰基-4-羟基-7-Q-1,8-二氮杂萘(IVA)是互变异构体,使IV(或IVA)与低级烷基化剂反应以产生3-乙酰基-1-(低级烷基) -1,4-二氢-7-Q-4-氧代-1,8-二氮杂萘(V)并将V转化为1-(低级烷基)-1,4-二氢-7-Q-4-氧代-1 (VI),其中Q是具有一个或两个低级烷基取代基的低级烷基,羟甲基,低级烷酰氧基甲基,4(或3) - 吡啶基或4(或3) - 吡啶基, Q'如Q,但不包括低级烷酰氧基甲基。 式VI化合物是已知的抗菌剂。 还给出了制备III和IV的替代途径,其中Q是低级烷酰氧基甲基,分别通过使III和IV的N-氧化物与低级链烷酸酐反应。
    • 10. 发明授权
    • N,N{40 -Heptamethylenebis(4-trifluoromethoxybenzamide)-{62 -cyclodextrin inclusion complex
    • N,N {40-七亚甲基双(4-三氟甲氧基苯甲酰胺) - {62-环糊精包合物
    • US3869443A
    • 1975-03-04
    • US36428973
    • 1973-05-29
    • STERLING DRUG INC
    • LESHER GEORGE Y
    • C07D209/48C07D295/092C08L3/02C08B25/02C07C103/30
    • C07D209/48C07C255/00C07D295/088
    • 4-(Q-O)-4''-R1-N,N''-alkylenebis(benzamides), N,N''alkylenebis(3,4-methylenedioxybenzamides) or N,N''-alkylenebis(4(lower-alkoxy)benzamides), having endocrinological properties, where Q is lower-alkyl, lower-alkoxyalkyl, lower-alkenyl, halolower-alkyl, halo-lower-alkenyl, lower-cycloalkyl, phenyl and BN(lower alkyl) where BN is di-(lower-alkyl)amino or a saturated Nheteromonocyclic radical having from five to seven ring atoms and alkylene has at least five carbon atoms between its two connecting linkages and R1 is Q-O-, hydrogen, lower-alkoxy, lower-alkyl, halo, benzyloxy, hydroxy, di-(lower-alkyl)amino, nitro, amino or trihalomethyl are prepared preferably by reacting the appropriate diamine or N-(aminoalkyl)-benzamide with two or one molar equivalents, respectively, of the appropriate benzoyl halide. The instant application relates particularly to N,N''heptamethylenebis(4-trifluoromethoxybenzamide)- Beta cyclodextrin inclusion complex, having antifertility activity.
    • 4-(QO)-4'-R1-N,N'-亚烷基双(苯甲酰胺),N,N'-亚烷基双(3,4-亚甲二氧基苯甲酰胺)或N,N'-亚烷基双[4-(低级烷氧基) ],具有内分泌学性质,其中Q为低级烷基,低级烷氧基烷基,低级烯基,卤代低级烷基,卤代低级烯基,低级环烷基,苯基和BN-(低级烷基) (低级烷基)氨基或具有5-7个环原子的饱和N-杂单环基团,并且亚烷基在其两个连接键之间具有至少五个碳原子,并且R 1是QO-,氢,低级烷氧基,低级 - 烷基,卤素 苄基氧基,羟基,二 - (低级 - 烷基)氨基,硝基,氨基或三卤代甲基优选通过使合适的二胺或N-(氨基烷基) - 苯甲酰胺与适当的苯甲酰卤的2或1摩尔当量反应来制备。 本申请特别涉及具有抗生育活性的N,N'-七亚甲基双(4-三氟甲氧基苯甲酰胺)-β-环糊精包合物。